Glaxo in $13 Billion Consumer Push as Novartis Narrows Focus
Scientist mixes chemicals inside the new lab at the GlaxoSmithKline Plc facility in Collegeville, Pennsylvania, U.S. (Photographer: Eric Thayer/Bloomberg)

Glaxo in $13 Billion Consumer Push as Novartis Narrows Focus

Bookmark
(Bloomberg) -- The new bosses of two of Europe’s largest drugmakers are pivoting in different directions, with GlaxoSmithKline Plc doubling down on consumer health as Novartis AG narrows its focus ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.